Veeva Systems Inc. $VEEV Holdings Raised by Bath Savings Trust Co

Bath Savings Trust Co increased its position in shares of Veeva Systems Inc. (NYSE:VEEV) by 10.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,886 shares of the technology company’s stock after acquiring an additional 3,965 shares during the period. Veeva Systems comprises approximately 1.2% of Bath Savings Trust Co’s portfolio, making the stock its 23rd biggest holding. Bath Savings Trust Co’s holdings in Veeva Systems were worth $12,478,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Veeva Systems during the 2nd quarter valued at $384,265,000. Durable Capital Partners LP acquired a new stake in Veeva Systems in the 2nd quarter valued at approximately $281,351,000. AQR Capital Management LLC grew its stake in shares of Veeva Systems by 111.7% in the second quarter. AQR Capital Management LLC now owns 1,838,046 shares of the technology company’s stock worth $526,508,000 after acquiring an additional 969,905 shares during the last quarter. Schroder Investment Management Group increased its holdings in shares of Veeva Systems by 1,039.4% during the 2nd quarter. Schroder Investment Management Group now owns 1,014,974 shares of the technology company’s stock worth $292,292,000 after purchasing an additional 925,896 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its stake in Veeva Systems by 20.9% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,992,372 shares of the technology company’s stock valued at $924,754,000 after acquiring an additional 689,700 shares during the period. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently issued reports on VEEV. TD Cowen upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating and increased their price objective for the company from $297.00 to $380.00 in a research note on Tuesday, October 7th. Barclays lowered their target price on Veeva Systems from $325.00 to $305.00 and set an “overweight” rating for the company in a research note on Friday, November 21st. Evercore ISI boosted their price objective on shares of Veeva Systems from $285.00 to $295.00 and gave the stock an “in-line” rating in a research report on Thursday, August 28th. Needham & Company LLC reissued a “buy” rating and set a $355.00 price objective on shares of Veeva Systems in a report on Friday, November 21st. Finally, BMO Capital Markets started coverage on Veeva Systems in a research note on Thursday, November 13th. They issued a “market perform” rating and a $300.00 price target on the stock. Eighteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, Veeva Systems currently has a consensus rating of “Moderate Buy” and an average price target of $307.42.

Veeva Systems Stock Up 1.0%

Shares of NYSE:VEEV opened at $217.70 on Friday. The firm has a market cap of $35.78 billion, a price-to-earnings ratio of 42.35, a PEG ratio of 1.60 and a beta of 1.05. The company’s fifty day simple moving average is $266.77 and its 200 day simple moving average is $277.30. Veeva Systems Inc. has a 12 month low of $201.54 and a 12 month high of $310.50.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 earnings per share for the quarter, topping the consensus estimate of $1.95 by $0.09. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The company had revenue of $0.81 million during the quarter, compared to analysts’ expectations of $792.37 million. During the same period in the prior year, the firm earned $1.75 earnings per share. Veeva Systems’s revenue for the quarter was up 16.0% compared to the same quarter last year. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. Research analysts expect that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the completion of the transaction, the insider directly owned 23,773 shares in the company, valued at $7,132,850.92. This represents a 12.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Jonathan Faddis sold 720 shares of the stock in a transaction that occurred on Monday, October 6th. The shares were sold at an average price of $298.12, for a total value of $214,646.40. Following the transaction, the senior vice president directly owned 7,868 shares of the company’s stock, valued at $2,345,608.16. This trade represents a 8.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 24,665 shares of company stock valued at $7,438,000 in the last three months. 10.30% of the stock is currently owned by corporate insiders.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.